News

Pharmabiz11h
Granules India completes aquisition of Swiss- based CDMO, Senn Chemicals
Granules India completes aquisition of Swiss- based CDMO, Senn Chemicals: Our Bureau, Mumbai Friday, April 11, 2025, 12:10 ...
Pharmabiz5h
First-ever MHRA analysis of UK clinical trial applications finds new opportunities to drive medical breakthroughs for patients
First-ever MHRA analysis of UK clinical trial applications finds new opportunities to drive medical breakthroughs for patients: United Kingdom Friday, April 11, 2025, 18:00 Hrs [I ...
Pharmabiz6h
Isotopia introduces Isoprotrace, an innovative diagnostic solution for prostate cancer imaging, in UK
Isotopia Molecular Imaging, a global leader in radiopharmaceutical, announced the official launch of Isoprotrace, its advanced Gallium-68 Gozetotide preparation kit for prostate cancer imaging, in the ...
Pharmabiz7h
Researchers map unprecedented detail of connections and visual perception in the mouse brain
Researchers map unprecedented detail of connections and visual perception in the mouse brain: Bethesda, Maryland Friday, April 11, 2025, 16:00 Hrs [IST] In a massive scientific ef ...
Pharmabiz7h
Maharashtra FDA cracks down on clandestine, illegal cosmetic operations in Bhiwandi
Maharashtra FDA cracks down on clandestine, illegal cosmetic operations in Bhiwandi: Our Bureau, Mumbai Friday, April 11, 2025, 16:15 Hrs [IST] In a prompt and timely enforcement ...
Pharmabiz14h
GC Biopharma gets Korean Ministry of Food and Drug Safety approval for BARYTHRAX, the world’s first recombinant anthrax vaccine
Yong-in, South Korea Friday, April 11, 2025, 09:00 Hrs [IST] ...
Pharmabiz8h
Agitated Solutions receives IND application clearance from US FDA to begin phase 3 clinical trial for its novel contrast agent, ASI-02
Agitated Solutions receives IND application clearance from US FDA to begin phase 3 clinical trial for its novel contrast agent, ASI-02: St. Paul, Minn. Friday, April 11, 2025, 15: ...
Pharmabiz11h
Darnatein secures intellectual property protection for its protein-based osteoarthritis treatment technology to expand global market
Seoul, South Korea Friday, April 11, 2025, 12:00 Hrs [IST] ...
Pharmabiz13h
Valneva SE, LimmaTech vaccinate first participant in phase 2 infant study of tetravalent Shigella vaccine candidate S4V2
Saint Herblain (France) & Schlieren (Zurich) Friday, April 11, 2025, 10:00 Hrs [IST] ...
Pharmabiz9h
Proprio’s AI surgical guidance platform, Paradigm receives US FDA 510(k) clearance
Proprio’s AI surgical guidance platform, Paradigm receives US FDA 510(k) clearance: Seattle Friday, April 11, 2025, 14:00 Hrs [IST] Proprio, the global leader in AI-powered surg ...
Pharmabiz10h
New research to tackle challenges facing NHS and care workforce
New research to tackle challenges facing NHS and care workforce: United Kingdom Friday, April 11, 2025, 13:00 Hrs [IST] £24 million will be invested in 5 innovative new research ...
Pharmabiz15h
Experts concerned over promotional strategies of Eli Lilly for tirzepatide
Experts concerned over promotional strategies of Eli Lilly for tirzepatide: Shardul Nautiyal, Mumbai Friday, April 11, 2025, 08:00 Hrs [IST] As Mounjaro (tirzepatide), the blockbu ...